TherapeuticsMD, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
TherapeuticsMD, Inc. (TXMD) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$355.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2024-03-29
- TherapeuticsMD, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2022-12-31 was -$74.00K.
- TherapeuticsMD, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2022-09-30 was $7.00K.
- TherapeuticsMD, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2022 was -$355.00K.
- TherapeuticsMD, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2021 was -$2.22M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$67.00K derived: sum of 2 quarters · filed 2024-03-29 | -$355.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$281.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$288.00K 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | -$2.22M 10-K · filed 2023-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |